ADHD Telehealth Platforms vs. a Real Evaluation

Home > ADHD > Telehealth Apps vs. In-Person Evaluation

I have published in JAMA Psychiatry on telehealth oversight and the risks of unregulated digital psychiatry platforms. I also treat patients by telehealth across four jurisdictions. So this is not an argument against telehealth. It is an argument about evaluation depth, which is a different thing.

What these platforms get right

Worth stating, because the criticism is usually one-sided.

They solved an access problem that was real. Wait times for psychiatric evaluation in most of the country run months. They removed geography, scheduling friction, and a great deal of stigma. A large number of adults — particularly women diagnosed decades late — got a correct diagnosis and effective treatment they would not otherwise have pursued.

That is a genuine public health contribution and it should not be dismissed.

What the brief-evaluation model misses

The problem is not the screen. It is what a 20-minute visit and a rating scale cannot establish.

Developmental history. DSM-5-TR requires evidence that several symptoms were present before age 12. Establishing that takes real history-taking — school patterns, recurring feedback themes, family recollection. It is the criterion most often skipped, and skipping it is why the model errs in both directions.

Differential screening. Every one of these produces a positive ADHD screen:

• Obstructive sleep apnea or chronic insufficient sleep
• Thyroid dysfunction
• Anxiety disorders
• Depression
• PTSD and trauma
• Daily cannabis use
• Autism
• Bipolar disorder

Prescribing a stimulant to someone whose actual problem is untreated sleep apnea or an anxiety disorder makes that problem worse. Prescribing one to someone with daily heavy cannabis use addresses neither condition.

Impairment across settings. ADHD requires difficulty in two or more contexts. Difficulty in one points elsewhere.

The scale is not the diagnosis. ASRS and CAARS are screening instruments with high sensitivity and modest specificity. They are designed to catch people who warrant evaluation, not to complete one. Using a screen as the decision inverts what it was built for.

The structural problem

There is an incentive issue worth naming plainly. A platform whose revenue depends on subscription volume, whose clinicians are compensated per visit, and whose visits are 20 minutes has no mechanism that rewards concluding "this isn't ADHD."

That is not an accusation about any individual clinician, most of whom are conscientious people working inside a system they did not design. It is an observation about what the system selects for. Federal enforcement actions in this sector over the past few years have concerned exactly these dynamics.

How to tell a real evaluation from a screen

Ask before booking:

1. How long is the initial evaluation? Under 45 minutes is a screen.
2. Do you take a developmental history establishing symptoms before age 12? If they don't ask about childhood, they are not applying DSM criteria.
3. What do you screen for besides ADHD? A real answer names sleep, thyroid, anxiety, depression, trauma, substance use, autism.
4. Will I be prescribed at the first visit? Sometimes appropriate. Guaranteed at the first visit is a red flag.
5. Who will I see for follow-up? Rotating clinicians make titration difficult and treatment relationships impossible.

Telehealth done properly

I evaluate and treat ADHD by telehealth in New York, Virginia, Montana, and — by out-of-state telehealth registration — Florida.

The evaluation is the same 60–90 minutes it would be in the office. Same developmental history, same differential, same collateral. The video connection changes the logistics, not the standard.

Controlled substance prescribing by telehealth carries specific regulatory requirements that have changed repeatedly and continue to. I'll tell you directly what applies to your situation rather than after you've paid.

Related

Adult ADHD evaluation · ADHD psychiatrist NYC · Neuropsych testing vs. psychiatric evaluation · AI and digital psychiatry research · How to choose a psychiatrist

Frequently Asked Questions

Are online ADHD diagnoses legitimate?

A telehealth ADHD diagnosis can be entirely legitimate — the format is not the issue. What matters is whether the evaluation included a developmental history, assessment of impairment across settings, and screening for conditions that mimic ADHD. A thorough 90-minute telehealth evaluation is better than a rushed 20-minute in-person one.

How long should an ADHD evaluation take?

60 to 90 minutes, sometimes across two visits. Anything under 45 minutes cannot cover the developmental history and differential screening that a DSM-5-TR diagnosis requires.

Can an online ADHD test diagnose me?

No. Rating scales like the ASRS have high sensitivity and modest specificity — they identify who should be evaluated, not who has ADHD. No self-report instrument establishes the diagnosis.

What if I was diagnosed by a telehealth app and treatment isn't working?

Worth reevaluating. Common findings are an untreated condition producing the symptoms, an incomplete initial evaluation, or inadequate titration. See second opinions.

Can I get ADHD medication through telehealth?

Often yes, subject to controlled substance regulations that have changed repeatedly and vary by state and situation. Any clinician should be able to tell you clearly what applies to you before you book.

Is in-person evaluation better than telehealth for ADHD?

Not inherently. Evaluation depth matters far more than modality. A comprehensive telehealth evaluation outperforms a superficial in-person one.